Simvastatin
Tocris Bioscience, part of Bio-Techne | Catalog # 1965
HMG-CoA reductase inhibitor
Product Description
Simvastatin is a HMG-CoA reductase inhibitor; decreases levels of low density lipoprotein. Simvastatin is also an AMPK activator. Has multiple biological effects including bone formation stimulation, inhibition of smooth muscle cell proliferation and migration, induction of ferroptosis, inhibition of autophagy, and anticancer and anti-inflammatory activity. Inactive lactone prodrug of simvastatin hydroxy acid, naturally bioactivated in vivo following oral administration.Simvastatin acts synergistically with ABL allosteric inhibitors GNF 5 (Cat. No. 1965) to enhance apoptosis of metastatic lung cancer cells in mice.Product Specifications
Molecular Weight
418.57
Formula
C25H38O5
Storage
Desiccate at -20°C
Purity
≥98% (HPLC)
Chemical Name
(1S,3R,7S,8S,8aR)-1,2,3,7,8,8a-Hexahydro-3,7-dimethyl-8-[2-[(2R,4R)-tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl]ethyl]-1-naphthalenyly-2,2-dimethyl butanoate
CAS Number
79902-63-9
PubChem ID
54454
InChI Key
RYMZZMVNJRMUDD-HGQWONQESA-N
SMILES
[H][C@@]12C(C=C[C@H](C)[C@@H]2CC[C@@H]3C[C@@H](O)CC(O3)=O)=C[C@H](C)C[C@@H]1OC(C(C)(C)CC)=O
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
Solubility
| Solvent | Max Conc. mg/mL | Max Conc. mM | |
|---|---|---|---|
| Solubility | |||
| DMSO | 20.93 | 50 | |
| Ethanol | 31.39 | 75 |
Preparing Stock Solutions
for Simvastatin
The following data is based on the product molecular weight 418.57
Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which all affect the solvent volumes required to prepare stock solutions.
| Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
|---|---|---|---|
| 0.75 mM | 3.19 mL | 15.93 mL | 31.85 mL |
| 3.75 mM | 0.64 mL | 3.19 mL | 6.37 mL |
| 7.5 mM | 0.32 mL | 1.59 mL | 3.19 mL |
| 37.5 mM | 0.06 mL | 0.32 mL | 0.64 mL |
Calculators
Molarity Calculator
Dilution Calculator
Reconstitution Calculator
Background References
References are publications that support the biological activity of the product.
- Dehnavi Targeting AMPK by statins: A potential therapeutic approach. Drugs 2021 PMID: 33939118
- Luttman ABL allosteric inhibitors synergize with statins to enhance apoptosis of metastatic lung cancer cells. Cell Rep. 2021 PMID: 34706244
- Reinoso Preclinical pharmacokinetics of STAT. Methods Find.Exp.Clin.Pharmacol. 2002 PMID: 12616706
- White Pharmacological effects of HMG CoA reductase inhibitors other than lipoprotein modulation. J.Clin.Pharmacol. 1999 PMID: 11563401
- Kaushal Potential anticancer effects of STAT: fact or fiction? Endothelium 2003 PMID: 12699077
- Garrett STAT and bone formation. Curr.Pharm.Des. 2001 PMID: 11405194
Product Specific Notices for Simvastatin
For research use only
Loading...
Loading...
Loading...